Patents by Inventor Ben NEEL

Ben NEEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PD-1 related cancer therapy
    Patent number: 11110171
    Abstract: Provided are compositions and methods for identifying individuals with cancer who will benefit from PD-1 inhibitor therapy. The method comprises determining levels of signaling lymphocyte activation molecule-associated protein (SAP) in an individual and based on the SAP levels, determining if the individual is suitable for PD-1 inhibitor therapy. Also provided is a method of treatment of X-linked lymphoproliferative disease comprising administering to an individual PD-1 inhibitory therapy, with or without SHP2 inhibitors.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: September 7, 2021
    Assignee: New York University
    Inventors: Adam Mor, Ben Neel
  • PD-1 RELATED CANCER THERAPY
    Publication number: 20200330595
    Abstract: Provided are compositions and methods for identifying individuals with cancer who will benefit from PD-1 inhibitor therapy. The method comprises determining levels of signaling lymphocyte activation molecule-associated protein (SAP) in an individual and based on the SAP levels, determining if the individual is suitable for PD-1 inhibitor therapy. Also provided is a method of treatment of X-linked lymphoproliferative disease comprising administering to an individual PD-1 inhibitory therapy, with or without SHP2 inhibitors.
    Type: Application
    Filed: December 21, 2018
    Publication date: October 22, 2020
    Inventors: Adam MOR, Ben NEEL